| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/19/2003 | EP1283716A1 Vaccine comprising a tick cement protein |
| 02/19/2003 | EP1056777A4 Ligand receptors and uses therefor |
| 02/19/2003 | EP0699237B1 Anti-egfr single-chain fvs and anti-egfr antibodies |
| 02/19/2003 | CN1398300A Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 02/19/2003 | CN1398299A BZIP type transcripton factors regulating expression of rice storage protein |
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/18/2003 | US6521816 Nucleic acid molecules from rice and their use for the production of modified starch |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521749 GL50 nucleic acids and uses therefor |
| 02/18/2003 | US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity |
| 02/18/2003 | US6521743 Monoclonal antibodies; screening and diagnosis of Alzheimer*s, Parkinson*s, Huntington*s, neurodegenerative, amyotrophic lateral sclerosis, Creutzfeldt-Joseph's disease, and apoptosis-concerning protein diseases |
| 02/18/2003 | US6521741 Catalytic antibodies and a method of producing same |
| 02/18/2003 | US6521598 Peptide consisting of an amino acid sequence 1: SPSVDKARAEL; induces transplant tolerance |
| 02/18/2003 | US6521593 Using antagonists of integrins such as alpha v beta 3 and alpha v beta 5; inhibiting angiogenesis and vitronectin and tenascin mediated cell adhesion; inducing apoptosis |
| 02/18/2003 | US6521442 Polynucleotide compositions encoding broad spectrum δ-endotoxins |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521436 Gene expression; drug screening for antiarthritic agents; bone disorders |
| 02/18/2003 | US6521432 Methods for enhancing the rate of modification of metastable bonds |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521416 Determination of the amount of hLHβ core fragment in a sample from a subject and uses thereof |
| 02/18/2003 | US6521415 Tandem immuno-assay for cancer |
| 02/18/2003 | US6521413 Bioassay; monitoring cells for changes in ion channel activity |
| 02/18/2003 | US6521407 Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors |
| 02/18/2003 | US6521404 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface |
| 02/18/2003 | US6521403 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 02/18/2003 | US6521230 CD25 binding molecules |
| 02/18/2003 | US6521228 Monoclonal antibodies having preferential binding to human tumor necrosis factor related apoptosis inducing ligand(TRAIL) polypeptides; cytokines used as anticarcinogenic agents |
| 02/18/2003 | US6521227 Monoclonal or polyclonal antibodies having preferential binding to polypeptides used as prostate specific antigens |
| 02/18/2003 | US6521226 Administering Paraoxonase-1 (PON-1), an expressed protein that has hydrolase activity for organophosphates, and antioxidation activity for low-density lipoprotein (LDL) |
| 02/18/2003 | CA2100591C Avirulent anti-rabies vaccine |
| 02/18/2003 | CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19 |
| 02/18/2003 | CA2071211C Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 02/18/2003 | CA2067031C Dna coding for human cell surface antigen |
| 02/17/2003 | CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 02/13/2003 | WO2003012444A1 Method and kit for typing feline blood |
| 02/13/2003 | WO2003012146A1 Modular assembly of nucleic acid-protein fusion multimers |
| 02/13/2003 | WO2003012143A1 Genes and snps associated with eating disorders |
| 02/13/2003 | WO2003012141A1 Method of screening alzheimer’s disease-associated gene |
| 02/13/2003 | WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization |
| 02/13/2003 | WO2003012126A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | WO2003012107A1 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/13/2003 | WO2003012089A2 Crystal structure of beta-site app cleaving enzyme (bace) and use thereof |
| 02/13/2003 | WO2003012072A2 Monoclonal antibodies to activated erbb family members and methods of use thereof |
| 02/13/2003 | WO2003012069A2 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | WO2003012026A1 Apparatus and method for determining the onset and presence of sepsis conditions |
| 02/13/2003 | WO2003011911A1 Substance specific to pd-1 |
| 02/13/2003 | WO2003011910A2 Anti-ssrp-1 monoclonal antibodies and hybridomas producing said antibodies |
| 02/13/2003 | WO2003011909A1 Binding agents with differential activity |
| 02/13/2003 | WO2003011908A2 Mutant forms of the tgf-b type ii receptor which bind all tgf-b isoforms and the use thereof |
| 02/13/2003 | WO2003011907A2 Receptor, the use thereof, and mouse antibodies |
| 02/13/2003 | WO2003011905A1 Novel serine protease |
| 02/13/2003 | WO2003011903A2 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 02/13/2003 | WO2003011902A1 Identification of specific tumour antigens by selection of cdna libraries with sera |
| 02/13/2003 | WO2003011899A2 Antigenic polypeptides |
| 02/13/2003 | WO2003011898A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 02/13/2003 | WO2003011878A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | WO2003011337A1 MEDICINAL COMPOSITIONS CONTAINING Fc RECEPTOR Ϝ-CHAIN ACTIVATOR |
| 02/13/2003 | WO2003011335A2 Polyvalent vaccine against diseases caused by papilloma viruses, method for the production and the use thereof |
| 02/13/2003 | WO2003011106A2 Internal image antibodies for optical imaging and therapy |
| 02/13/2003 | WO2003011020A1 Imaging marker transgenes |
| 02/13/2003 | WO2002096948A9 Engineered tetravalent antibodies and methods of use |
| 02/13/2003 | WO2002096457A3 Stable liquid formulations of antibodies |
| 02/13/2003 | WO2002085924A9 ANTI-α3(IV)NC1 MONOCLONAL ANTIBODIES AND ANIMAL MODEL FOR HUMAN ANTI-GLOMERULAR BASEMENT MEMBRANE AUTOANTIBODY DISEASE |
| 02/13/2003 | WO2002078638A3 Morpholino imaging and therapy |
| 02/13/2003 | WO2002070648A3 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 02/13/2003 | WO2002069232A3 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 02/13/2003 | WO2002066514A3 Artificial fusion proteins with reduced immunogenicity |
| 02/13/2003 | WO2002053723B1 Degradation and detection of tse infectivity |
| 02/13/2003 | WO2002048321A3 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 02/13/2003 | WO2002046466A3 Complexes of brca and stat polypeptides and methods of use in the detection and treatment of cancer |
| 02/13/2003 | WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 02/13/2003 | WO2002033114A3 Protein-protein interactions in neurodegenerative diseases |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2002018565A3 Regulation of human protein phosphatase iic-like enzyme |
| 02/13/2003 | WO2002018443A3 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 02/13/2003 | WO2002006515A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/13/2003 | US20030033616 Imaging marker transgenes |
| 02/13/2003 | US20030032792 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of gastrointestinal, crohn's, inflammatory bowel, diabetes and cancer, |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032782 Cmposition for use in the treatment of arthritis, narcolepsy rheumatoid arthritis, multiple sclerosis, grave's, diabetes, psoriasis, myasthenia gravis, glomerulonephritis, thyroiditis, pancreatitis, cirrhosis, and irritable bowel diseases |
| 02/13/2003 | US20030032772 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/13/2003 | US20030032609 Promoting agniogenesis with a compound that increases expression of VEGF; inhibiting angiogenesis with a compound that inhibits binding of endothelial PAS domain protein-1 to cis-acting transcription regulatory DNA an angiogenic factor. |
| 02/13/2003 | US20030032595 Compositions and methods relating to glucose metabolism, weight control, and food intake |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032098 Bone morphogenic protein |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides |
| 02/13/2003 | US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region |
| 02/13/2003 | US20030032073 Method for diagnosis and therapy of Hodgkin's lymphomas |
| 02/13/2003 | US20030032070 Methods for diagnosing and treating alzheimer's disease and parkinson's disease |